IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q3 2018 Holdings

Filed 2018-11-14 | 17 holdings | $118.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$30.5K4,062,79125.8%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$29.6K2,359,76725.1%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$27.9K749,81523.6%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$6.3K484,0965.3%
Electrocore Inc(ECORGBP)COM28531P103$5.7K396,8254.8%
Krystal Biotech Inc(KRYS)COM501147102$5.1K300,0004.3%
Galmed Pharmaceuticals Ltd(GLMD)SHSM47238106$2.9K210,0002.4%
Entera Bio Ltd(ENTX)SHSM40527109$2.4K475,5402.0%
Anavex Life Sciences Corp(AVXL)COM NEW032797300$1.9K724,2051.6%
Soligenix Inc.COM834223307$1.5K837,8001.3%
Vascular Biogenics LTDCOMM96883109$1.5K896,7711.3%
Volition RX LTD(VNRX)COM928661107$916321,4130.8%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$91075,2380.8%
Evoke Pharma IncCOM30049G104$825275,0000.7%
Chromadex Corp(NAGE)COM NEW171077407$19247,8660.2%
Catasys IncCOM149049504$1029,0810.1%
Lipocine Inc NewCOM53630X104$6950,0000.1%